Laurie Robak, Ph.D. - Publications
Affiliations: | University of Rochester, Rochester, NY |
Area:
mechanisms of myelin inhibition, spinal cord regenerationYear | Citation | Score | |||
---|---|---|---|---|---|
2009 | Robak LA, Venkatesh K, Lee H, Raiker SJ, Duan Y, Lee-Osbourne J, Hofer T, Mage RG, Rader C, Giger RJ. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 5768-83. PMID 19420245 DOI: 10.1523/Jneurosci.4935-08.2009 | 0.635 | |||
2008 | Giger RJ, Venkatesh K, Chivatakarn O, Raiker SJ, Robak L, Hofer T, Lee H, Rader C. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems. Restorative Neurology and Neuroscience. 26: 97-115. PMID 18820405 | 0.519 | |||
2008 | Lee H, Raiker SJ, Venkatesh K, Geary R, Robak LA, Zhang Y, Yeh HH, Shrager P, Giger RJ. Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 2753-65. PMID 18337405 DOI: 10.1523/Jneurosci.5586-07.2008 | 0.617 | |||
2001 | Dattatreyamurty B, Roux E, Horbinski C, Kaplan PL, Robak LA, Beck HN, Lein P, Higgins D, Chandrasekaran V. Cerebrospinal fluid contains biologically active bone morphogenetic protein-7. Experimental Neurology. 172: 273-81. PMID 11716552 DOI: 10.1006/Exnr.2001.7728 | 0.313 | |||
Show low-probability matches. |